Thomas John VAN BLARCOM

Person

Oakland, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Chimeric antigen receptors targeting CD70
- Patent number 12,152,081
- Issue date Nov 26, 2024
- Pfizer Inc.
- Surabhi Srivatsa Srinivasan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified caspase-9 polypeptides and methods of use thereof
- Patent number 12,104,188
- Issue date Oct 1, 2024
- Allogene Therapeutics, Inc.
- Meritxell Galindo Casas
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Constitutively active chimeric cytokine receptors
- Patent number 12,043,655
- Issue date Jul 23, 2024
- Allogene Therapeutics, Inc.
- Regina Junhui Lin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
BCMA CAR-T cells with enhanced activities
- Patent number 12,036,243
- Issue date Jul 16, 2024
- Allogene Therapeutics, Inc.
- Regina Junhui Lin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antibodies specific for CD70 and their uses
- Patent number 11,987,634
- Issue date May 21, 2024
- Pfizer Inc.
- Siler Panowski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chimeric antigen receptors targeting B-cell maturation antigen
- Patent number 11,912,776
- Issue date Feb 27, 2024
- Pfizer Inc.
- Tracy Chia-Chien Kuo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic antibodies and their uses
- Patent number 11,814,435
- Issue date Nov 14, 2023
- Pfizer Inc.
- Tracy Chia-Chien Kuo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chimeric cytokine receptors bearing a PD-1 ectodomain
- Patent number 11,786,553
- Issue date Oct 17, 2023
- ALLOGENE THERAPEUCTICS, INC.
- Regina Junhui Lin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies specific for CD47, PD-L1, and uses thereof
- Patent number 11,702,474
- Issue date Jul 18, 2023
- Pfizer Inc.
- Javier Fernando Chaparro Riggers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
DLL3 targeting chimeric antigen receptors and binding agents
- Patent number 11,673,953
- Issue date Jun 13, 2023
- Allogene Therapeutics, Inc.
- Yi Zhang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Chimeric antigen receptors targeting CD70
- Patent number 11,396,551
- Issue date Jul 26, 2022
- Pfizer Inc.
- Surabhi Srivatsa Srinivasan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies specific for CD70 and their uses
- Patent number 11,377,500
- Issue date Jul 5, 2022
- Pfizer Inc.
- Siler Panowski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified caspase-9 polypeptides and methods of use thereof
- Patent number 11,326,156
- Issue date May 10, 2022
- Allogene Therapeutics, Inc.
- Meritxell Galindo Casas
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Chimeric antigen receptors targeting B-cell maturation antigen
- Patent number 11,312,782
- Issue date Apr 26, 2022
- Pfizer Inc.
- Tracy Chia-Chien Kuo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Therapeutic antibodies and their uses
- Patent number 11,155,630
- Issue date Oct 26, 2021
- Pfizer Inc.
- Tracy Chia-Chien Kuo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic antibodies and their uses
- Patent number 10,793,635
- Issue date Oct 6, 2020
- Pfizer Inc.
- Tracy Chia-Chien Kuo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chimeric antigen receptors targeting B-cell maturation antigen
- Patent number 10,294,304
- Issue date May 21, 2019
- Pfizer Inc.
- Tracy Chia-Chien Kuo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic antibodies and their uses
- Patent number 10,040,860
- Issue date Aug 7, 2018
- Pfizer Inc.
- Tracy Chia-Chien Kuo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic antibodies and their uses
- Patent number 9,969,809
- Issue date May 15, 2018
- Pfizer Inc.
- Tracy Chia-Chien Kuo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-glucagon receptor antibodies and pharmaceutical compositions t...
- Patent number 9,248,189
- Issue date Feb 2, 2016
- Pfizer Inc.
- Alison Jane Forgie
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
CLAUDIN 18.2 TARGETING CHIMERIC ANTIGEN RECEPTORS AND BINDING AGENT...
- Publication number 20240216430
- Publication date Jul 4, 2024
- Allogene Therapeutics, Inc.
- Zhe LI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Specific for CD47, PD-L1, and Uses Thereof
- Publication number 20240124591
- Publication date Apr 18, 2024
- Pfizer Inc.
- Javier Fernando CHAPARRO RIGGERS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
B-CELL MATURATION ANTIGEN (BCMA) ANTI-IDIOTYPIC ANTIBODIES
- Publication number 20240101710
- Publication date Mar 28, 2024
- Allogene Therapeutics, Inc.
- Zea Melton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
THERAPEUTIC ANTIBODIES AND THEIR USES
- Publication number 20240018252
- Publication date Jan 18, 2024
- Pfizer Inc.
- Tracy Chia-Chien KUO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHIMERIC CYTOKINE RECEPTORS BEARING A PD-1 ECTODOMAIN
- Publication number 20240016846
- Publication date Jan 18, 2024
- Allogene Therapeutics, Inc.
- Regina Junhui LIN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DLL3 TARGETING CHIMERIC ANTIGEN RECEPTORS AND BINDING AGENTS
- Publication number 20230287120
- Publication date Sep 14, 2023
- Allogene Therapeutics, Inc.
- Yi ZHANG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODIES HAVING CONDITIONAL AFFINITY AND METHODS OF USE THEREOF
- Publication number 20230192839
- Publication date Jun 22, 2023
- Pfizer Inc.
- Bijan Andre BOLDAJIPOUR
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHIMERIC ANTIGEN RECEPTORS TARGETING CD70
- Publication number 20230041456
- Publication date Feb 9, 2023
- Pfizer Inc.
- Surabhi SRIVATSA SRINIVASAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES SPECIFIC FOR CD70 AND THEIR USES
- Publication number 20230002498
- Publication date Jan 5, 2023
- Pfizer Inc.
- Siler Panowski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE TARGETING OF HOST CD70+ ALLOREACTIVE CELLS TO PROLONG ALL...
- Publication number 20220409665
- Publication date Dec 29, 2022
- Allogene Therapeutics, Inc.
- Elvin J. LAURON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN
- Publication number 20220340671
- Publication date Oct 27, 2022
- Pfizer Inc.
- TRACY CHIA-CHIEN KUO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FASL EXPRESSION AND FASR GENE KNOCKOUT TO PROTECT THERAPEUTIC CELLS...
- Publication number 20220281950
- Publication date Sep 8, 2022
- Allogene Therapeutics, Inc.
- Michael Thomas BETHUNE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
KNOCKDOWN OR KNOCKOUT OF ONE OR MORE OF TAP2, NLRC5, B2m, TRAC, RFX...
- Publication number 20220251505
- Publication date Aug 11, 2022
- Allogene Therapeutics, Inc.
- Michael Thomas BETHUNE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED CASPASE-9 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20220235346
- Publication date Jul 28, 2022
- Allogene Therapeutics, Inc.
- Meritxell GALINDO CASAS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PROTEASE-ACTIVATING CD45-GATE CAR
- Publication number 20220227832
- Publication date Jul 21, 2022
- Allogene Therapeutics, Inc.
- Shanshan LANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHIMERIC ANTIGEN RECEPTORS WITH ENHANCED SIGNALING AND ACTIVITIES A...
- Publication number 20220023346
- Publication date Jan 27, 2022
- Allogene Therapeutics, Inc.
- Michael Thomas BETHUNE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BCMA CAR-T CELLS WITH ENHANCED ACTIVITIES
- Publication number 20210260118
- Publication date Aug 26, 2021
- Allogene Therapeutics, Inc.
- Regina Junhui LIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC ANTIBODIES AND THEIR USES
- Publication number 20210188991
- Publication date Jun 24, 2021
- Pfizer Inc.
- Tracy Chia-Chien KUO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Specific for CD47, PD-L1, and Uses Thereof
- Publication number 20210179716
- Publication date Jun 17, 2021
- Pfizer Inc.
- Javier Fernando CHAPARRO RIGGERS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DLL3 TARGETING CHIMERIC ANTIGEN RECEPTORS AND BINDING AGENTS
- Publication number 20210107979
- Publication date Apr 15, 2021
- Allogene Therapeutics, Inc.
- Yi ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHIMERIC CYTOKINE RECEPTORS COMPRISING TGF BETA BINDING DOMAINS
- Publication number 20210061881
- Publication date Mar 4, 2021
- Allogene Therapeutics, Inc.
- Regina Junhui LIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC ANTIBODIES AND THEIR USES
- Publication number 20210054087
- Publication date Feb 25, 2021
- Pfizer Inc.
- Tracy Chia-Chien KUO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMPROVED T CELL COMPOSITIONS AND METHODS
- Publication number 20200399343
- Publication date Dec 24, 2020
- Allogene Therapeutics, Inc.
- Javier Fernando CHAPARRO RIGGERS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CONSTITUTIVELY ACTIVE CHIMERIC CYTOKINE RECEPTORS
- Publication number 20200291090
- Publication date Sep 17, 2020
- Allogene Therapeutics, Inc.
- Regina Junhui LIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHIMERIC CYTOKINE RECEPTORS BEARING A PD-1 ECTODOMAIN
- Publication number 20200276238
- Publication date Sep 3, 2020
- Allogene Therapeutics, Inc.
- Regina Junhui LIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INDUCIBLE CHIMERIC CYTOKINE RECEPTORS
- Publication number 20190292533
- Publication date Sep 26, 2019
- Allogene Therapeutics, Inc.
- Andrew Ross NAGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN
- Publication number 20190241669
- Publication date Aug 8, 2019
- Pfizer Inc.
- Tracy Chia-Chien KUO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHIMERIC ANTIGEN RECEPTORS TARGETING CD70
- Publication number 20190233528
- Publication date Aug 1, 2019
- Pfizer Inc.
- Surabhi Srivatsa Srinivasan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES SPECIFIC FOR CD70 AND THEIR USES
- Publication number 20190233529
- Publication date Aug 1, 2019
- Pfizer Inc.
- Siler Panowski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED CASPASE-9 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20190127721
- Publication date May 2, 2019
- Allogene Therapeutics, Inc.
- Meritxell GALINDO CASAS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Thomas John VAN BLARCOM

Person

Patents Grantslast 30 patents

Chimeric antigen receptors targeting CD70

Modified caspase-9 polypeptides and methods of use thereof

Constitutively active chimeric cytokine receptors

BCMA CAR-T cells with enhanced activities

Antibodies specific for CD70 and their uses

Chimeric antigen receptors targeting B-cell maturation antigen

Therapeutic antibodies and their uses

Chimeric cytokine receptors bearing a PD-1 ectodomain

Antibodies specific for CD47, PD-L1, and uses thereof

DLL3 targeting chimeric antigen receptors and binding agents

Chimeric antigen receptors targeting CD70

Antibodies specific for CD70 and their uses

Modified caspase-9 polypeptides and methods of use thereof

Chimeric antigen receptors targeting B-cell maturation antigen

Therapeutic antibodies and their uses

Therapeutic antibodies and their uses

Chimeric antigen receptors targeting B-cell maturation antigen

Therapeutic antibodies and their uses

Therapeutic antibodies and their uses

Anti-glucagon receptor antibodies and pharmaceutical compositions t...

Patents Applicationslast 30 patents

CLAUDIN 18.2 TARGETING CHIMERIC ANTIGEN RECEPTORS AND BINDING AGENT...

Antibodies Specific for CD47, PD-L1, and Uses Thereof

B-CELL MATURATION ANTIGEN (BCMA) ANTI-IDIOTYPIC ANTIBODIES

THERAPEUTIC ANTIBODIES AND THEIR USES

CHIMERIC CYTOKINE RECEPTORS BEARING A PD-1 ECTODOMAIN

DLL3 TARGETING CHIMERIC ANTIGEN RECEPTORS AND BINDING AGENTS

ANTIBODIES HAVING CONDITIONAL AFFINITY AND METHODS OF USE THEREOF

CHIMERIC ANTIGEN RECEPTORS TARGETING CD70

ANTIBODIES SPECIFIC FOR CD70 AND THEIR USES

SELECTIVE TARGETING OF HOST CD70+ ALLOREACTIVE CELLS TO PROLONG ALL...

CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN

FASL EXPRESSION AND FASR GENE KNOCKOUT TO PROTECT THERAPEUTIC CELLS...

KNOCKDOWN OR KNOCKOUT OF ONE OR MORE OF TAP2, NLRC5, B2m, TRAC, RFX...

MODIFIED CASPASE-9 POLYPEPTIDES AND METHODS OF USE THEREOF

PROTEASE-ACTIVATING CD45-GATE CAR

CHIMERIC ANTIGEN RECEPTORS WITH ENHANCED SIGNALING AND ACTIVITIES A...

BCMA CAR-T CELLS WITH ENHANCED ACTIVITIES

THERAPEUTIC ANTIBODIES AND THEIR USES

Antibodies Specific for CD47, PD-L1, and Uses Thereof

DLL3 TARGETING CHIMERIC ANTIGEN RECEPTORS AND BINDING AGENTS

CHIMERIC CYTOKINE RECEPTORS COMPRISING TGF BETA BINDING DOMAINS

THERAPEUTIC ANTIBODIES AND THEIR USES

IMPROVED T CELL COMPOSITIONS AND METHODS

CONSTITUTIVELY ACTIVE CHIMERIC CYTOKINE RECEPTORS

CHIMERIC CYTOKINE RECEPTORS BEARING A PD-1 ECTODOMAIN

INDUCIBLE CHIMERIC CYTOKINE RECEPTORS

CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN

CHIMERIC ANTIGEN RECEPTORS TARGETING CD70

ANTIBODIES SPECIFIC FOR CD70 AND THEIR USES

MODIFIED CASPASE-9 POLYPEPTIDES AND METHODS OF USE THEREOF